ReMedi3+
Natural health product licensed in Canada
- Licence holder
- ReMediPhage Ltd.
- NPN or DIN-HM
- 80079296
- Status
- Active licence
- Licence date
- 31 July 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Curcuma longa Source : Rhizome | 1,000 milligramme | Not calculated |
| Lactobacillus plantarum Source : 15312 | 35 Milliards d'UFC | Not calculated |
| Lactobacillus plantarum Source : Cellule entière | 35 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : 13434 | 35 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : Cellule entière | 35 Milliards d'UFC | Not calculated |
| Zingiber officinale Source : Rhizome | 100 milligramme | Not calculated |
| Lactobacillus plantarum Source : 15313 | 35 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Fructooligosaccharides, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of probiotics, helps promote a favorable gut flora. Provides antioxidants for the maintenance of good health. Used in Herbal Medicine to help relieve joint inflammation. Used in Herbal Medicine as a hepatoprotectant/liver protectant. Traditionally used in Ayurveda to relieve pain and inflammation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. Consult a health care practitioner prior to use if you are pregnant. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid.
Source
Official Health Canada record, licence 80079296
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.